Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
Adès
Lionel
L
Service d'Hématologie clinique at the Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Avicenne, 93009 Bobigny, France.
Fenaux
Pierre
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D016896:Treatment Outcome
D003561:Cytarabine